Non-arrhythmogenic metabolite of oxybutynin
US6432446B1 · kind B1 · utility
11Cited by
8References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 1, 2001 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Feb 1, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating disorders involving the urethrogentical tract by administering to pateints in need therof therapeutically effective amounts of the desethyl metabolite of oxybutynin and/or the optically active isomers thereof, which are free from said cardiac side effect of oxybutynin, while maintaining the therapeutic activities of oxybutynin or the optically active isomers thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.